Tekla Life Sciences Investors Stock price
Compare with Peer Group
Is Tekla Life Sciences Investors a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.
Key metrics
Don't miss a Thing! We will send you all news about Tekla Life Sciences Investors directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tekla Life Sciences Investors Stock News
Company Profile
Tekla Life Sciences Investors operates as a closed-end investment fund or Investment trust. The firm engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.
| Head office | United States |
| CEO | Dan Omstead |
| Founded | 1992 |
| Website | www.aberdeeninvestments.com |


